NCT00261872View on ClinicalTrials.gov

Treatment of Patients With Alcoholism and Attention Deficit Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2005

Study Completion Date

April 9, 2007

Conditions
AlcoholismAttention Deficit Disorder
Interventions
DRUG

Methylphenidate

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT00261872 - Treatment of Patients With Alcoholism and Attention Deficit Disorder | Biotech Hunter | Biotech Hunter